{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreigbbdirz7cv7myrzt7igzeuedc6llezl5u4f5gegdvli6xomzanpy",
    "uri": "at://did:plc:vv5cq7qjnr2fd5ytohsyyegf/app.bsky.feed.post/3mgy4rkvs5n62"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiazecegjqi2idrxjkf6g5xtkdblmcauwjm6yikx7mucdnokffuvqe"
    },
    "mimeType": "image/jpeg",
    "size": 246789
  },
  "path": "/2026/03/a-new-drug-is-producing-stunning-results-in-men-with-advanced-prostate-cancer/",
  "publishedAt": "2026-03-13T00:00:02.000Z",
  "site": "https://www.optimistdaily.com",
  "tags": [
    "Evergreen",
    "Gender",
    "Health",
    "Medicine",
    "Science",
    "Technology",
    "advanced prostate cancer",
    "cancer",
    "health",
    "immune-cold cancer",
    "immunotherapy prostate cancer",
    "Medical Research",
    "men's health",
    "prostate cancer clinical trial",
    "prostate cancer cure 2026",
    "prostate cancer treatment",
    "prostate-specific antigen",
    "science",
    "T-cell engager cancer drug",
    "Vir Biotechnology",
    "VIR-5500",
    "A new drug is producing “stunning” results in men with advanced prostate cancer",
    "The Optimist Daily: Making Solutions the News"
  ],
  "textContent": "BY THE OPTIMIST DAILY EDITORIAL TEAM Immunotherapy has reshaped cancer treatment over the past decade. It has worked for melanoma, lung cancer, and several other tumor types. Prostate cancer, though, has largely been left out. Researchers classify it as “immune-cold,” meaning the body’s immune system doesn’t recognize or attack it effectively, making it resistant to […]\n\nThe post A new drug is producing “stunning” results in men with advanced prostate cancer first appeared on The Optimist Daily: Making Solutions the News.",
  "title": "A new drug is producing “stunning” results in men with advanced prostate cancer"
}